Options Exercise: Janux Executive Sells 16,665 Shares for $501,000

Janux's chief business officer unloaded 16.87% of his direct holdings in a routine insider sale. Meyer Andrew Hollman, Chief Business Officer at Janux Therapeutics (JANX 1.70%), exercised 16,665 options and immediately sold the resulting shares for a transaction value of approximately $501,000 on October 28, 2025, according to a recent SEC Form 4 filing.Transaction summaryMetricValueShares sold16,665Transaction value~$501,000Post-transaction shares82,139Post-transaction value (direct ownership)~$2,444,500Tr ...